Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy

Journal of Laryngology and Otology

Volumn 121, Issue 11, 2007, Pages 1048-1054

  Miziara, I D ^a,b   Weber, R ^a   Filho, B Cunha Araújo ^a   Neto, C Diógenes Pinheiro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Antiretroviral Therapy, Highly Active; Child; HIV; Otitis Media

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; GLYCOPROTEIN; INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; ZIDOVUDINE;

ARTICLE; BRAZIL; CHILD; COHORT ANALYSIS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PREVALENCE; T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CLASSIFICATION; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; OTITIS MEDIA; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 41449102476     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215107006093     Document Type: Article

References (28)

1. UNAIDS-Global HIV/AIDS 2004 Report http://www.unaids.org/EN/other/ functionalities/search.asp [9 May 2005]
2. Surveillance Health Secretary, Federal Health Department, Brazil. National Program of STD and AIDS (Brazil) AIDS cases (numbers and percentuals) in 13 years old or less individuals, categorized according sex and year of diagnostic, 1980-2004. AIDS and STD Epidemiologic Bulletin 2004;1:32
3. Hoare S. HIV infection in children - impact upon ENT doctors. Int J Pediatr Otorhinolaryngol 2003;67(suppl 1):S85-90
4. Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR III et al. Effects of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Eng J Med 2001;345:1522-8
5. Miziara ID, Valentini M, Romano FR, Miniti A. Changing patterns of buccal manifestations in AIDS. Rev Laryngol Otol Rhinol 2002;123:231-4
6. Shapiro NL, Novelli V. Otitis media in children with vertically-acquired HIV infection: the Great Ormond Street Hospital experience. Int J Pediatr Otorhinolaryngol 1998;45:69-75
7. Williams MA. Head and neck findings in pediatric acquired immune deficiency syndrome. Laryngoscope 1987;97:713-16
8. Rinaldo A, Brandwein MS, Devaney KO, Ferlito A. AIDS-related otological lesions. Acta Otolaryngol 2003;123:672-4
9. Barnett ED, Klein JO, Pelton SI, Lunginbuhl IM. Otitis media in children born to human immunodeficiency virus infected mothers. Pediatr Infect Dis J 1992;11:360-4
10. Caldwell MB, Oxtoby MJ, Simonds RJ, Lindegren ML, Rogers MF. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. CDC Morbidity Mortality Weekly Report 1994;43:1-10
11. Marchisio P, Principi N, Sorella S, Sala E, Tornaghi R. Etiology of acute otitis media in human immunodeficiency virus infected children. Pediatr Infect Dis J 1996;15:58-61
12. Roland PS. Chronic suppurative otitis media: a clinical overview. Ear Nose Throat J 2002;81(suppl1):8-10
13. Verhoeff M, van der Veen EL, Rovers MM, Schilder AG. Int J Pediatr Otorhinolaryngol 2006;70:1-12
14. Bernaldez PC, Morales G, Hernandez CM. Chronic suppurative otitis media in HIV-infected children: P140. Otolaryngol Head Neck Surg 2005;133(suppl 1):243-4
15. Bluestone CD. Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment. Int J Pediatr Otorhinolaryngol 1998;42:207-23
16. Chen AY, Ohlms LA, Stewart MG, Kline MW. Otolaryngologic disease progression in children with human immunodeficiency virus infection. Arch Otolaryngol Head Neck Surg 1996;122:1360-3
17. Chandrasekhar SS, Connelly PE, Brambhatt SS, Shah CS, Kloser PC, Baredes S. Otologic and audiologic evaluation of human immunodeficiency virus-infected patients. Am J Otolaryngol 2000;21:1-9
18. Chaloryoo S, Chotpitayasunondh T, Chiengmai PN. AIDS in ENT in children. Int J Pediatr Otorhinolaryngol 1998;44:103-7
19. Singh A, Georgalas C, Patel N, Papesch M. ENT presentations in children with HIV infection. Clin Otolaryngol 2003;28:240-3
20. Hadfield PJ, Birchall MA, Novelli V, Bailey CM. The ENT manifestations of HIV infection in children. Clin Otolaryngol Allied Sci 1996;21:30-6
21. Zuccotti GV, D'Auria E, Torcoletti M, Lodi F, Bernardo L, Riva E. Clinical and pro-host effects of cefaclor in prophylaxis of recurrent otitis media in HIV-infected children. J Int Med Res 2001;29:349-54
22. Makokha EP, Ogolla M, Orago AS, Koech DK, Mpoke S, Esamai F et al. CD4 T lymphocyte subsets and disease manifestation in children with and without HIV born to HIV-infected mothers. East Afr Med J 2003;80:95-100
23. Gondim LA, Zonta RF, Fortkamp E, Schmeling RO. Otorhinolaryngological manifestations in children with human immunodeficiency virus infection. Int J Pediatr Otorhinolaryngol 2000;54:97-102
24. Smirnova MG, Birchall JP, Pearson JP. Evidence of T-helper cell 2 cytokine regulation of chronic otitis media with effusion. Acta Otolaryngol 2005;125:1043-50
25. Skotnicka B, Stasiak-Barmuta A, Hassmann-Poznanska E, Kasprzycka E. Lymphocyte subpopulations in middle ear effusions: flow cytometry analysis. Otol Neurotol 2005;26:567-71
26. Granados JMS, Amador JTR, Miguel SF, Tomé MIG, Conejo PR, Vivas PF et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J 2003;22:863-7
27. Kline MW. Human immunodeficiency virus protease inhibitors. Pediatr Infect Dis J 2003;22:1085-8
28. Principi N. AIDS and the pediatric ENT specialist. Int J Pediatr Otorhinolaryngol 1995;32(suppl):S7-12